tradingkey.logo
tradingkey.logo
Search

Brainsway Ltd

BWAY
Add to Watchlist
15.190USD
-0.100-0.65%
Close 07/02, 13:00ETQuotes delayed by 15 min
594.93MMarket Cap
33.12P/E TTM

More Details of Brainsway Ltd Company

Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

Brainsway Ltd Info

Ticker SymbolBWAY
Company nameBrainsway Ltd
IPO dateDec 24, 2006
CEOLevy (Hadar)
Number of employees120
Security typeDepository Receipt
Fiscal year-endDec 24
Address16 Hartum Street Rad Tower, 14Th Floor
CityJERUSALEM
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code9777516
Phone97225813140
Websitehttps://www.brainsway.com/
Ticker SymbolBWAY
IPO dateDec 24, 2006
CEOLevy (Hadar)

Company Executives of Brainsway Ltd

Name
Name/Position
Position
Shareholding
Change
Dr. David Zacut, M.D.
Dr. David Zacut, M.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Dr. Yiftach Roth
Dr. Yiftach Roth
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Avner Hagai
Mr. Avner Hagai
Independent Director
Independent Director
--
--
Ms. Eti Michal Mitrany Rayten
Ms. Eti Michal Mitrany Rayten
Independent Director
Independent Director
--
--
Ms. Karen Sarid
Ms. Karen Sarid
Independent Director
Independent Director
--
--
Mr. Yosef (Yossi) Ben Shalom
Mr. Yosef (Yossi) Ben Shalom
Independent Director
Independent Director
--
--
Prof. Abraham Zangen, Ph.D.
Prof. Abraham Zangen, Ph.D.
Director
Director
--
--
Mr. Hadar Levy
Mr. Hadar Levy
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Avner Lushi
Mr. Avner Lushi
Independent Director
Independent Director
--
--
Mr. Christopher Boyer
Mr. Christopher Boyer
Vice President - Global Marketing
Vice President - Global Marketing
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. David Zacut, M.D.
Dr. David Zacut, M.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Dr. Yiftach Roth
Dr. Yiftach Roth
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Avner Hagai
Mr. Avner Hagai
Independent Director
Independent Director
--
--
Ms. Eti Michal Mitrany Rayten
Ms. Eti Michal Mitrany Rayten
Independent Director
Independent Director
--
--
Ms. Karen Sarid
Ms. Karen Sarid
Independent Director
Independent Director
--
--
Mr. Yosef (Yossi) Ben Shalom
Mr. Yosef (Yossi) Ben Shalom
Independent Director
Independent Director
--
--

FAQs

Who are the top five shareholders of Brainsway Ltd?

The top five shareholders of Brainsway Ltd are: Dr. David Zacut, M.D.

How many institutions hold shares of Brainsway Ltd (BWAY)?

As of 2026Q1, 95 institutions hold shares of Brainsway Ltd, with a combined market value of approximately 12.27M, accounting for 30.66% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -3188785.00.